Journal of Neuroimmunology
Volume 225, Issue 1 , Pages 91-99 , 25 August 2010

Differential expression of interferon-γ receptor on human glial cells in vivo and in vitro

  • Sadayuki Hashioka

      Affiliations

    • Kinsmen Laboratory of Neurological Research, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, B.C., V6T 1Z3, Canada
    • ,
  • Andis Klegeris

      Affiliations

    • Department of Biology, I.K. Barber School of Arts and Sciences, The University of British Columbia Okanagan, 3333 University Way, Kelowna, B.C., V1V 1V7, Canada
    • ,
  • Claudia Schwab

      Affiliations

    • Kinsmen Laboratory of Neurological Research, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, B.C., V6T 1Z3, Canada
    • ,
  • Sheng Yu

      Affiliations

    • Kinsmen Laboratory of Neurological Research, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, B.C., V6T 1Z3, Canada
    • ,
  • Patrick L. McGeer

      Affiliations

    • Kinsmen Laboratory of Neurological Research, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, B.C., V6T 1Z3, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +1 604 822 7377; fax: +1 604 822 7086.

Received 14 January 2010 ,Revised 3 April 2010 ,Accepted 29 April 2010.

References 

  1. Bach EA, Aguet M, Schreiber RD. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 1997;15:563–591
  2. Benveniste EN. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 1998;9:259–275
  3. Benveniste EN, Benos DJ. TNF-alpha- and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function. FASEB J. 1995;9:1577–1584
  4. Boyle EA, McGeer PL. Cellular immune response in multiple sclerosis plaques. Am. J. Pathol. 1990;137:575–584
  5. De Groot CJ, Montagne L, Janssen I, Ravid R, Van Der Valk P, Veerhuis R. Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue. Brain Res. Brain Res. Protoc. 2000;5:85–94
  6. Dheen ST, Kaur C, Ling EA. Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 2007;14:1189–1197
  7. Folkerth RD, Keefe RJ, Haynes RL, Trachtenberg FL, Volpe JJ, Kinney HC. Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol. 2004;14:265–274
  8. Giulian D, Baker TJ. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 1986;6:2163–2178
  9. Hashioka S, Han YH, Fujii S, Kato T, Monji A, Utsumi H, et al. Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid beta and interferon-gamma-induced microglial activation. Free Radic. Biol. Med. 2007;42:945–954
  10. Hashioka S, Miklossy J, Schwab C, Klegeris A, McGeer PL. Adhesion of exogenous human microglia and THP-1 cells to amyloid plaques of postmortem Alzheimer's disease brain. J. Alzheimers Dis. 2008;14:345–352
  11. Hashioka S, Klegeris A, Schwab C, McGeer PL. Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiol. Aging. 2009;30:1924–1935
  12. Itagaki S, McGeer PL, Akiyama H. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci. Lett. 1988;91:259–264
  13. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 1992;140:691–707
  14. Kim SU. Neurobiology of human oligodendrocytes in culture. J. Neurosci. Res. 1990;27:712–728
  15. Kim SU, Moretto G, Shin DH, Lee VM. Modulation of antigenic expression in cultured adult human oligodendrocytes by derivatives of adenosine 3′, 5′-cyclic monophosphate. J. Neurol. Sci. 1985;69:81–91
  16. Klegeris A, Bissonnette CJ, McGeer PL. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br. J. Pharmacol. 2003;139:775–786
  17. Klegeris A, Bissonnette CJ, McGeer PL. Modulation of human microglia and THP-1 cell toxicity by cytokines endogenous to the nervous system. Neurobiol. Aging. 2005;26:673–682
  18. Lundkvist GB, Robertson B, Mhlanga JD, Rottenberg ME, Kristensson K. Expression of an oscillating interferon-gamma receptor in the suprachiasmatic nuclei. NeuroReport. 1998;9:1059–1063
  19. McGeer EG, Klegeris A, McGeer PL. Inflammation, the complement system and the diseases of aging. Neurobiol. Aging. 2005;26(Suppl 1):94–97
  20. Meda L, Cassatella MA, Szendrei GI, Otvos L, Baron P, Villalba M, et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 1995;374:647–650
  21. Miklossy J, Doudet DD, Schwab C, Yu S, McGeer EG, McGeer PL. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp. Neurol. 2006;197:275–283
  22. Neumann H. Control of glial immune function by neurons. Glia. 2001;36:191–199
  23. Popko B, Corbin JG, Baerwald KD, Dupree J, Garcia AM. The effects of interferon-gamma on the central nervous system. Mol. Neurobiol. 1997;14:19–35
  24. Qing H, Zhang Y, Deng Y, McGeer EG, McGeer PL. Lrrk2 interaction with alpha-synuclein in diffuse Lewy body disease. Biochem. Biophys. Res. Commun. 2009;390:1229–1234
  25. Robertson B, Xu XJ, Hao JX, Wiesenfeld-Hallin Z, Mhlanga J, Grant G, et al. Interferon-gamma receptors in nociceptive pathways: role in neuropathic pain-related behaviour. NeuroReport. 1997;8:1311–1316
  26. Robertson B, Kong G, Peng Z, Bentivoglio M, Kristensson K. Interferon-gamma-responsive neuronal sites in the normal rat brain: receptor protein distribution and cell activation revealed by Fos induction. Brain Res. Bull. 2000;52:61–74
  27. Rubio N, de Felipe C. Demonstration of the presence of a specific interferon-gamma receptor on murine astrocyte cell surface. J. Neuroimmunol. 1991;35:111–117
  28. Slepko N, Levi G. Progressive activation of adult microglial cells in vitro. Glia. 1996;16:241–246
  29. Stampachiacchiere B, Aloe L. Differential modulatory effect of NGF on MHC class I and class II expression in spinal cord cells of EAE rats. J. Neuroimmunol. 2005;169:20–30
  30. Torres C, Aranguez I, Rubio N. Expression of interferon-gamma receptors on murine oligodendrocytes and its regulation by cytokines and mitogens. Immunology. 1995;86:250–255
  31. Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, Inoue K. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 2009;106:8032–8037
  32. Valente G, Ozmen L, Novelli F, Geuna M, Palestro G, Forni G, et al. Distribution of interferon-gamma receptor in human tissues. Eur. J. Immunol. 1992;22:2403–2412
  33. Vikman K, Robertson B, Grant G, Liljeborg A, Kristensson K. Interferon-gamma receptors are expressed at synapses in the rat superficial dorsal horn and lateral spinal nucleus. J. Neurocytol. 1998;27:749–759
  34. Wang Y, Zhou CF. Involvement of interferon-gamma and its receptor in the activation of astrocytes in the mouse hippocampus following entorhinal deafferentation. Glia. 2005;50:56–65
  35. Wang Y, Ren Z, Tao D, Tilwalli S, Goswami R, Balabanov R. STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells. Glia. 2010;58:195–208

PII: S0165-5728(10)00183-9

doi: 10.1016/j.jneuroim.2010.04.023

Journal of Neuroimmunology
Volume 225, Issue 1 , Pages 91-99 , 25 August 2010

Article Tools

* Image Usage & Resolution